Results 231 to 240 of about 17,129 (242)
Structural basis for amyloid fibril assembly by the master cell-signaling regulator receptor-interacting protein kinase 1. [PDF]
Polonio P +7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
RIPK1 and RIPK3 in antibacterial defence
Biochemical Society Transactions, 2022Upon sensing pathogenic bacterial infection, host cells activate a multitude of inflammatory and immunogenic responses to promote bacterial clearance and restore tissue homeostasis. RIPK1 and RIPK3 are two key players in antimicrobial defence, by either driving inflammatory signalling or inducing programmed cell death activation, ranging from apoptosis,
Hui Wen Yeap, Kaiwen W. Chen
openaire +2 more sources
Mechanisms of RIPK3‐induced inflammation
Immunology & Cell Biology, 2017Receptor‐interacting protein kinase 3 (RIP3/RIPK3) is a multifunctional regulator of cell death and inflammation. It controls signalling downstream of the tumor necrosis factor (TNF) receptor family, DNA‐dependent activator of IFN‐regulatory factors (DAI) and toll‐like receptors (TLRs).
Inbar Shlomovitz +2 more
openaire +2 more sources
Ring closure strategy leads to potent RIPK3 inhibitors
European Journal of Medicinal Chemistry, 2021Necroptosis is a form of regulated necrotic cell death that is independent of caspases. Receptor-interacting protein kinase 3 (RIPK3) has been identified as a key regulator for necroptosis, and has been proposed as a potential therapeutic target for the treatment of diseases associated with necroptosis. In this report, we describe the design, synthesis,
Shuwei, Wu +9 more
openaire +2 more sources
c-Abl activates RIPK3 signaling in Gaucher disease
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2021Gaucher disease (GD) is caused by homozygous mutations in the GBA1 gene, which encodes the lysosomal β-glucosidase (GBA) enzyme. GD affects several organs and tissues, including the brain in certain variants of the disease. Heterozygous GBA1 variants are a major genetic risk factor for developing Parkinson's disease.
Yañez Henríquez, María José +6 more
openaire +3 more sources
Inhibitors Targeting RIPK1/RIPK3: Old and New Drugs
Trends in Pharmacological Sciences, 2020The scaffolding function of receptor-interacting protein kinase 1 (RIPK1) regulates prosurvival signaling and inflammatory gene expression, while its kinase activity mediates both apoptosis and necroptosis; the latter involving RIPK3 kinase activity.
Martens, Sofie +4 more
openaire +3 more sources
Targeting RIPK3 oligomerization blocks necroptosis without inducing apoptosis
FEBS Letters, 2020Receptor‐interacting serine/threonine‐protein kinase 3 (RIPK3) is a central protein in necroptosis with great potential as a target for treating necroptosis‐associated diseases, such as Crohn's disease. However, blockade of RIPK3 kinase activity leads to unexpected RIPK3‐initiated apoptosis.
Wenjuan Li +9 more
openaire +2 more sources
Detection of Necroptosis by Phospho-RIPK3 Immunohistochemical Labeling
2018Activation of the kinase RIPK3 (receptor interacting protein kinase 3) is a hallmark of cells dying by necroptosis. RIPK3 phosphorylates both itself and the pseudokinase MLKL (mixed lineage kinase-like) resulting in MLKL translocation to membranes and cell lysis.
Joshua D, Webster +3 more
openaire +2 more sources
RIPK1 and RIPK3 form mosaic necrosomes
Nature Cell Biology, 2022Weiwei Qi, Junying Yuan
openaire +2 more sources
While recent work has identified roles for immune mediators in the regulation of neural activity, the capacity for cell intrinsic innate immune signaling within neurons to influence neurotransmission remains poorly understood. However, the existing evidence linking immune signaling with neuronal function suggests that modulation of neurotransmission ...
openaire +1 more source
openaire +1 more source

